Another example is AFM24 (CD16A-NKCEs), a bispecific IgG1-scFv fusion antibody targeting CD16A on innate immune NK cells and epidermal growth factor receptor (EGFR) on tumor cells, effectively targeting tumors expressing human epidermal growth factor receptor at similar levels (127). Here, FCGR3A is linked to neoplasm.